Search by Drug Name or NDC

NDC 53002-1686-05 ISENTRESS 400 mg/1 Details

ISENTRESS 400 mg/1

ISENTRESS is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is RALTEGRAVIR POTASSIUM.

MedlinePlus Drug Summary

Raltegravir is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children who weigh at least 4.5 lbs (2 kg). Raltegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in the blood. Although raltegravir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.

Related Packages: 53002-1686-05
Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Raltegravir

Product Information

NDC	53002-1686
Product ID	53002-1686_8843daf4-719e-4ecf-b3fa-fd9eef8df018
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	ISENTRESS
Proprietary Name Suffix	n/a
Non-Proprietary Name	RALTEGRAVIR
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	400
Active Ingredient Units	mg/1
Substance Name	RALTEGRAVIR POTASSIUM
Labeler Name	RPK Pharmaceuticals, Inc.
Pharmaceutical Class	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022145
Listing Certified Through	2024-12-31

Package

NDC 53002-1686-05 (53002168605)

Pricing Information	N/A
NDC Package Code	53002-1686-5
Billing NDC	53002168605
Package	15 TABLET, FILM COATED in 1 BOTTLE (53002-1686-5)
Marketing Start Date	2022-01-01
NDC Exclude Flag	N